Ocugen, Inc.
OCGN
$2.67
$0.3414.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -193.00K | 1.75M | 1.37M | 1.48M | 764.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -193.00K | 1.75M | 1.37M | 1.48M | 764.00K |
| Cost of Revenue | 10.67M | 11.15M | 8.40M | 786.00K | 8.29M |
| Gross Profit | -10.86M | -9.40M | -7.03M | 695.00K | -7.53M |
| SG&A Expenses | 6.13M | 8.23M | 6.77M | 6.45M | 6.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -477.00K | 1.32M | -- | -- | -153.00K |
| Total Operating Expenses | 16.33M | 20.70M | 15.17M | 15.98M | 14.45M |
| Operating Income | -16.52M | -18.94M | -13.80M | -14.50M | -13.69M |
| Income Before Tax | -17.71M | -20.05M | -14.74M | -15.35M | -13.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.71M | -20.05M | -14.74M | -15.35M | -13.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.71M | -20.05M | -14.74M | -15.35M | -13.88M |
| EBIT | -16.52M | -18.94M | -13.80M | -14.50M | -13.69M |
| EBITDA | -15.92M | -17.99M | -12.87M | -13.59M | -13.09M |
| EPS Basic | -0.06 | -0.07 | -0.05 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.06 | -0.07 | -0.05 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 312.34M | 304.00M | 292.07M | 292.00M | 290.92M |
| Average Diluted Shares Outstanding | 312.34M | 304.00M | 292.07M | 292.00M | 290.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |